Search Results 1-10 of 14370 for ������������������������������������������������r���:za33���

  1. R. Wright, M.D. - Mayo Clinic Faculty Profiles

    At Mayo Clinic, R. Scott Wright, M.D., focuses his research on improved diagnosis, treatment and patient outcomes in acute coronary syndromes and treatment ...

  2. Infection and Immunity: Raymund R. Razonable - Mayo Clinic Research

    The Infection and Immunity Lab of Raymund R. Razonable, M.D., at Mayo Clinic studies COVID-19 and transplant-related infections such as cytomegalovirus ...

  3. Clinical trials - Oncology (Medical)

    ... (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose ...

  4. Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ - Mayo Clinic

    Subjects will be randomized 1:1 to R-CHOP plus enzastaurin or R CHOP (plus placebo during induction). All subjects will receive up to 6 cycles (3 weeks per ...

  5. A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

    This Phase 2, two-arm, open-label study is designed to evaluate the safety, clinical activity, predictive biomarkers and pharmacokinetics/ pharmacodynamics of ...

  6. Raymund R. Razonable, M.D. - Mayo Clinic Faculty Profiles

    Raymund R. Razonable, M.D., is an infectious disease specialist at Mayo Clinic who studies viral infections, cytomegalovirus and infections related to ...

  7. R. Ross Reichard, M.D. - Mayo Clinic Faculty Profiles

    The primary research focus of R. Ross Reichard, M.D., is the neuropathological characterization of the brains of individuals who have been enrolled in large ...

  8. AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL - Mayo Clinic

    AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...

  9. A Study of Tyrosine Kinase Inhibitor ICP-022 in Patients With r/r B-Cell Malignancies - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Validation of Uroflow Trace (R) Mobile Application - Mayo Clinic

    The purpose of this study is to see if the Uroflow Trace (r) mobile application provides an accurate representation of urinary flow tracing by comparing it to a ...